Hong Kong Winhealth Pharma Group (hereinafter referred to as “Winhealth Pharma”) participated in a research project on regenerative medicine and cell therapy conducted in The University of Tokyo Hospital, which has achieved great progress. The research achievements were presented at the 17th Forum of 22nd Century Medical Center Seminar held in The University of Tokyo Hospital during March 14th - 18th, 2022.

On the afternoon of April 22, the launching ceremony of the “Relay for Life– Public Welfare Program for Treatment of Children with HGPS” was successfully held at the Lakeside Branch of the Children’s Hospital of Zhejiang University School of Medicine. Ms. Wang Qi, General Manager of Zhejiang Medical Technology Development Co., Ltd. (a wholly-owned subsidiary of Hong Kong Winhealth Pharma Group), attended the launching ceremony and the subsequent donation ceremony as a donor representative.